|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-20
|
|
pubmed:abstractText |
We conducted this 6-week open-label trial to examine the effects of adjunctive aripiprazole in clozapine-treated subjects on weight, lipid and glucose metabolism, as well as positive and negative symptoms of schizophrenia.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0001-690X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
142-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16423166-Adult,
pubmed-meshheading:16423166-Ambulatory Care,
pubmed-meshheading:16423166-Antipsychotic Agents,
pubmed-meshheading:16423166-Blood Glucose,
pubmed-meshheading:16423166-Body Mass Index,
pubmed-meshheading:16423166-Body Weight,
pubmed-meshheading:16423166-Cholesterol,
pubmed-meshheading:16423166-Clozapine,
pubmed-meshheading:16423166-Community Mental Health Centers,
pubmed-meshheading:16423166-Drug Therapy, Combination,
pubmed-meshheading:16423166-Female,
pubmed-meshheading:16423166-Follow-Up Studies,
pubmed-meshheading:16423166-Humans,
pubmed-meshheading:16423166-Male,
pubmed-meshheading:16423166-Middle Aged,
pubmed-meshheading:16423166-Piperazines,
pubmed-meshheading:16423166-Psychiatric Status Rating Scales,
pubmed-meshheading:16423166-Psychotic Disorders,
pubmed-meshheading:16423166-Quinolones,
pubmed-meshheading:16423166-Schizophrenia,
pubmed-meshheading:16423166-Triglycerides
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
|
|
pubmed:affiliation |
Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA. dchenderson@partners.org.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
